Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-06-30

Clinical Trial Results: A Study to Evaluate the Efficacy and Safety of Tirbanibulin Ointment in Adult Participants With Actinic Keratosis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of tirbanibulin ointment for actinic keratosis in adults completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • tirbanibulin ointment (tirbanibulin)

Snippet

Sponsor: Almirall, S.A. | Conditions: Keratosis, Actinic | Phase 3 | Status: COMPLETED | Results posted: 2026-06-30